Dr. Sankarasubramoney H. Subramony, MD

Dr. Subramony practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Subramony's NPI, 1194739995, was assigned on July 28, 2006. Dr. Subramony graduated from Maulana Azad Medical College in 1971. Dr. Subramony holds Florida license ME104927.

Dr. Subramony's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Subramony's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Subramony to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Subramony practices. Vendor and product names are available with a free account.

Neurology is Dr. Subramony's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Subramony is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Subramony's licenses on file in 2 states: Florida and Mississippi.

Dmand AI lists hereditary polyneuropathy, lower back pain, muscle disease and neuropathy among the conditions Dr. Subramony treats.

CMS data shows 112 Medicare services from Dr. Subramony across 4 procedure codes in 2024, for 95 Medicare patients. Medicare paid $10,260 for them. Every service was in an office.

CMS counts 95 Medicare patients who saw Dr. Subramony in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Subramony's median patient age at 56, with 48% women.

In 2024, Dr. Subramony wrote 187 Medicare Part D claims for 32 patients. 56% of them were for generic drugs. CMS names the drug for 138 of them, across 7 drugs with 11 or more claims each, at $1,660,082 in total drug cost. In 2023, CMS named 84 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Subramony for performance year 2024, reported through an alternative payment model (APM). Dr. Subramony accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Subramony as offering telehealth.

Dmand AI links 115 papers to Dr. Subramony, published from 2005 to 2024. 2019 was the busiest year, with 5. The most frequent topics are Phenotype, Spinocerebellar Ataxias and Electromyography. Dr. Subramony has published most often in Neurology. Dr. Subramony's most frequent co-authors are Tetsuo Ashizawa, MD, David R. Lynch and Susan Lee Perlman, MD.

Dmand AI links Dr. Subramony to 4 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Machado-Joseph Disease, Spinocerebellar Ataxias and Friedreich Ataxia. Biogen sponsors the most, 2.

CMS Open Payments shows 33 general payments to Dr. Subramony from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 67% of the total. Biogen, Inc. paid the most, $7,633.

Dmand AI lists 12 awards for Dr. Subramony, most recently CMS Stage 1 EHR in 2013.

Dr. Subramony graduated from Maulana Azad Medical College in 1971.

Dr. Subramony is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.